Tranquilli Financial Advisor’s Amneal Pharmaceuticals AMRX Stock Holding History

Tranquilli Financial Advisor’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-51,414	Closed	-$407K	–	110
2024 Q4	$407K	Hold	51,414	–	–	0.26%	73
2024 Q3	$428K	Sell	51,414 -20,000	-28%	-$156K	0.27%	72
2024 Q2	$458K	Hold	71,414	–	–	0.31%	70
2024 Q1	$433K	Hold	71,414	–	–	0.29%	73
2023 Q4	$433K	Hold	71,414	–	–	0.31%	65
2023 Q3	$301K	Hold	71,414	–	–	0.22%	75
2023 Q2	$221K	Hold	71,414	–	–	0.16%	85
2023 Q1	$99.3K	Hold	71,414	–	–	0.07%	81
2022 Q4	$142K	Hold	71,414	–	–	0.11%	79
2022 Q3	$144K	Hold	71,414	–	–	0.11%	68
2022 Q2	$227K	Hold	71,414	–	–	0.17%	60
2022 Q1	$298K	Hold	71,414	–	–	0.21%	68
2021 Q4	$342K	Hold	71,414	–	–	0.24%	63
2021 Q3	$381K	Hold	71,414	–	–	0.29%	52
2021 Q2	$366K	Hold	71,414	–	–	0.27%	55
2021 Q1	$481K	Hold	71,414	–	–	0.39%	45
2020 Q4	$326K	Buy	+71,414	New	+$316K	0.3%	52

Other funds holding AMRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tranquilli Financial Advisor's AMRX Position: Q1 2025 in Review

Tranquilli Financial Advisor sold out of Amneal Pharmaceuticals (AMRX) in Q1 2025, closing a stake of 51,414 shares — an estimated $407K sold.

Tranquilli Financial Advisor first reported a position in AMRX in Q4 2020 and held it in 17 quarters. The position peaked at $481K in Q1 2021. 237 funds tracked by Wall St. Rank hold AMRX as of Q1 2025.

Tranquilli Financial Advisor reported no remaining Amneal Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Tranquilli Financial Advisor sold 51,414 Amneal Pharmaceuticals shares in Q1 2025, an estimated $407K.
Tranquilli Financial Advisor first reported a position in Amneal Pharmaceuticals in Q4 2020 and held it in 17 quarters.
Tranquilli Financial Advisor's Amneal Pharmaceuticals position peaked at $481K in Q1 2021.
237 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2025.

Based on Tranquilli Financial Advisor's 13F filing for Q1 2025, filed 12 May 2025.